Sodium-Glucose Cotransporter 2 Inhibitors Ameliorate Ascites and Peripheral Edema in Patients With Cirrhosis and Diabetes

Hepatology. 2020 Nov;72(5):1880-1882. doi: 10.1002/hep.31270.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Ascites / drug therapy*
  • Ascites / etiology
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Edema / drug therapy*
  • Edema / etiology
  • Female
  • Glucose / metabolism
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / drug therapy
  • Male
  • Middle Aged
  • Renal Elimination / drug effects
  • Sodium / metabolism
  • Sodium-Glucose Transporter 2 Inhibitors / administration & dosage*
  • Treatment Outcome

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Sodium
  • Glucose